CureGBM’s professional exhibition presence at EUFUS Vienna 2026. The booth showcases the company’s mission to advance Sonodynamic Therapy for glioblastoma patients in Europe. Key elements visible: branded roll-up banner with layered neural imagery, clinical trial timeline (2026 Feasibility Study, 2027/28 Efficacy Trial, 2029 Start Treatments), printed collateral materials, and branded merchandise. The clean, clinical design combined with warm colour accents reflects CureGBM’s brand identity: Swiss precision meeting human compassion. Set in an elegant library environment, the booth positions CureGBM as a serious, credible clinical-stage MedTech company bringing evidence-based innovation to European cancer care.
